Next Article in Journal
Cost-Effectiveness of Lapatinib plus Letrozole in her2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer in Canada
Previous Article in Journal
Tony Pawson OC OOnt CH FRS FRSC
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Predicting the Risk of Cardiovascular Comorbidities in Adult Cancer Survivors

1
University of British Columbia, Vancouver, BC, Canada
2
Division of Medical Oncology, BC Cancer Agency, Vancouver, BC, Canada
*
Authors to whom correspondence should be addressed.
Curr. Oncol. 2013, 20(5), 360-370; https://doi.org/10.3747/co.20.1470
Submission received: 2 July 2013 / Revised: 10 August 2013 / Accepted: 14 September 2013 / Published: 1 October 2013

Abstract

Objectives: Data on how to identify cancer survivors (CSS) at the greatest risk for cardiovascular conditions are limited. We aimed to characterize the clinical factors associated with ischemic heart disease (IHD) and congestive heart failure (CHF) in CSS and to develop a stratification schema for predicting the risk of cardiovascular comorbidities in CSS. Methods: Cancer survivors and non-cancer controls (NCCS) were identified from the U.S. National Health and Nutrition Examination Survey. Independent factors associated with increased relative risk (RR) for cardiovascular conditions were determined. A risk stratification schema was devised that correlated risk score with the prevalence of cardiovascular comorbidities in CS. Results: Baseline characteristics were similar for the 1869 CSS and 24,337 NCCS included in the study. Compared with NCCS, CSS were more likely to report IHD (13.7% vs. 5.2%), CHF (7.9% vs. 2.1%), or both (4.2% vs. 1.2%; all p < 0.01). Based on multivariate analyses, risk factors for cardiovascular problems included ages 40–60 years RR: 3.66; 95% CI: 1.87 to 7.17), 60–80 years RR: 14.18; 95% CI: 7.65 to 26.30), and 80 years or older RR: 25.34; 95% CI: 13.16 to 48.78); male sex RR: 2.25; 95% CI: 1.72 to 2.94); U.S. citizenship RR: 2.10; 95% CI: 1.08 to 4.08); annual incomes of $20,000–$45,000 RR: 1.81; 95% CI: 1.21 to 2.70) and less than $20,000 RR: 3.05; 95% CI: 1.81 to 5.14); comorbid diabetes mellitus RR: 2.97; 95% CI: 2.05 to 4.32); and physical inactivity RR: 1.98; 95% CI: 1.41 to 2.79). Conclusions: Independent risk factors for IHD and CHF in CSS were identified. The risk stratification schema presented here may be helpful in developing a risk-based approach to preventive cardiovascular strategies for CSS.
Keywords: cardiovascular; comorbidities; survivors cardiovascular; comorbidities; survivors

Share and Cite

MDPI and ACS Style

Tashakkor, A.Y.; Moghaddamjou, A.; Chen, L.; Cheung, W.Y. Predicting the Risk of Cardiovascular Comorbidities in Adult Cancer Survivors. Curr. Oncol. 2013, 20, 360-370. https://doi.org/10.3747/co.20.1470

AMA Style

Tashakkor AY, Moghaddamjou A, Chen L, Cheung WY. Predicting the Risk of Cardiovascular Comorbidities in Adult Cancer Survivors. Current Oncology. 2013; 20(5):360-370. https://doi.org/10.3747/co.20.1470

Chicago/Turabian Style

Tashakkor, A.Y., A. Moghaddamjou, L. Chen, and W.Y. Cheung. 2013. "Predicting the Risk of Cardiovascular Comorbidities in Adult Cancer Survivors" Current Oncology 20, no. 5: 360-370. https://doi.org/10.3747/co.20.1470

APA Style

Tashakkor, A. Y., Moghaddamjou, A., Chen, L., & Cheung, W. Y. (2013). Predicting the Risk of Cardiovascular Comorbidities in Adult Cancer Survivors. Current Oncology, 20(5), 360-370. https://doi.org/10.3747/co.20.1470

Article Metrics

Back to TopTop